109 related articles for article (PubMed ID: 3606645)
1. Effects of methoxsalen on the metabolism of acetaminophen in humans.
Amouyal G; Larrey D; Letteron P; Geneve J; Labbe G; Belghiti J; Pessayre D
Biochem Pharmacol; 1987 Jul; 36(14):2349-52. PubMed ID: 3606645
[TBL] [Abstract][Full Text] [Related]
2. Pre- or post-treatment with methoxsalen prevents the hepatotoxicity of acetaminophen in mice.
Letteron P; Descatoire V; Larrey D; DeGott C; Tinel M; Geneve J; Pessayre D
J Pharmacol Exp Ther; 1986 Nov; 239(2):559-67. PubMed ID: 3772810
[TBL] [Abstract][Full Text] [Related]
3. The drug methoxsalen, a suicide substrate for cytochrome P-450, decreases the metabolic activation, and prevents the hepatotoxicity, of carbon tetrachloride in mice.
Labbe G; Descatoire V; Letteron P; Degott C; Tinel M; Larrey D; Carrion-Pavlov Y; Geneve J; Amouyal G; Pessayre D
Biochem Pharmacol; 1987 Mar; 36(6):907-14. PubMed ID: 3105541
[TBL] [Abstract][Full Text] [Related]
4. Methoxsalen decreases the metabolic activation and prevents the hepatotoxicity and nephrotoxicity of chloroform in mice.
Lettéron P; Degott C; Labbe G; Larrey D; Descatoire V; Tinel M; Pessayre D
Toxicol Appl Pharmacol; 1987 Nov; 91(2):266-73. PubMed ID: 3118512
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of human liver cytochrome P-450 by the drug methoxsalen and other psoralen derivatives.
Tinel M; Belghiti J; Descatoire V; Amouyal G; Letteron P; Geneve J; Larrey D; Pessayre D
Biochem Pharmacol; 1987 Mar; 36(6):951-5. PubMed ID: 3494453
[TBL] [Abstract][Full Text] [Related]
6. Suicide inactivation of cytochrome P-450 by methoxsalen. Evidence for the covalent binding of a reactive intermediate to the protein moiety.
Labbe G; Descatoire V; Beaune P; Letteron P; Larrey D; Pessayre D
J Pharmacol Exp Ther; 1989 Sep; 250(3):1034-42. PubMed ID: 2506333
[TBL] [Abstract][Full Text] [Related]
7. Direct protection against acetaminophen hepatotoxicity by propylthiouracil. In vivo and in vitro studies in rats and mice.
Yamada T; Ludwig S; Kuhlenkamp J; Kaplowitz N
J Clin Invest; 1981 Mar; 67(3):688-95. PubMed ID: 7204554
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of acetaminophen activation by ethanol and acetaldehyde in liver microsomes.
Sato C; Liu J; Miyakawa H; Nouchi T; Tanaka Y; Uchihara M; Marumo F
Life Sci; 1991; 49(24):1787-91. PubMed ID: 1943482
[TBL] [Abstract][Full Text] [Related]
9. Methoxsalen is a potent inhibitor of the metabolism of caffeine in humans.
Mays DC; Camisa C; Cheney P; Pacula CM; Nawoot S; Gerber N
Clin Pharmacol Ther; 1987 Dec; 42(6):621-6. PubMed ID: 3690940
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro.
Zhang W; Kilicarslan T; Tyndale RF; Sellers EM
Drug Metab Dispos; 2001 Jun; 29(6):897-902. PubMed ID: 11353760
[TBL] [Abstract][Full Text] [Related]
11. Effects of sulphur-containing compounds on paracetamol activation and covalent binding in a mouse hepatic microsomal system.
Tredger JM; Smith HM; Davis M; Williams R
Toxicol Lett; 1980 Apr; 5(5):339-44. PubMed ID: 7385255
[TBL] [Abstract][Full Text] [Related]
12. Effect of fasting on metabolite-mediated hepatotoxicity in the rat.
Pessayre D; Dolder A; Artigou JY; Wandscheer JC; Descatoire V; Degott C; Benhamou JP
Gastroenterology; 1979 Aug; 77(2):264-71. PubMed ID: 109346
[TBL] [Abstract][Full Text] [Related]
13. Microsomal oxidative damage promoted by acetaminophen metabolism.
Letelier ME; López-Valladares M; Peredo-Silva L; Rojas-Sepúlveda D; Aracena P
Toxicol In Vitro; 2011 Oct; 25(7):1310-3. PubMed ID: 21569833
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of the preventive effect of ethanol on acetaminophen-induced hepatoxicity.
Sato C; Lieber CS
J Pharmacol Exp Ther; 1981 Sep; 218(3):811-5. PubMed ID: 7264963
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of cytochrome P-450 by the drug methoxsalen.
Fouin-Fortunet H; Tinel M; Descatoire V; Letteron P; Larrey D; Geneve J; Pessayre D
J Pharmacol Exp Ther; 1986 Jan; 236(1):237-47. PubMed ID: 3941395
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of acetaminophen oxidation and toxicity by cimetidine and other histamine H2-receptor antagonists in vivo and in vitro in the rat and in man.
Mitchell MC; Schenker S; Speeg KV
J Clin Invest; 1984 Feb; 73(2):383-91. PubMed ID: 6142056
[TBL] [Abstract][Full Text] [Related]
17. Effect of L-ascorbic acid on acetaminophen-induced hepatotoxicity and covalent binding in hamsters. Evidence that in vitro covalent binding differs from that in vivo.
Miller MG; Jollow DJ
Drug Metab Dispos; 1984; 12(3):271-9. PubMed ID: 6145552
[TBL] [Abstract][Full Text] [Related]
18. Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen.
Koenigs LL; Peter RM; Thompson SJ; Rettie AE; Trager WF
Drug Metab Dispos; 1997 Dec; 25(12):1407-15. PubMed ID: 9394031
[TBL] [Abstract][Full Text] [Related]
19. Interaction of caffeine with acetaminophen. 1. Correlation of the effect of caffeine on acetaminophen hepatotoxicity and acetaminophen bioactivation following treatment of mice with various cytochrome P450 inducing agents.
Jaw S; Jeffery EH
Biochem Pharmacol; 1993 Aug; 46(3):493-501. PubMed ID: 8347173
[TBL] [Abstract][Full Text] [Related]
20. Single-dose methoxsalen effects on human cytochrome P-450 2A6 activity.
Kharasch ED; Hankins DC; Taraday JK
Drug Metab Dispos; 2000 Jan; 28(1):28-33. PubMed ID: 10611136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
